Ali Ashrafzadeh

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

The Lancet Rheumatology · 2020 · 220 citations

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week…

Arthritis & Rheumatism · 2012 · 53 citations